These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 11839661

  • 21. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I.
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [Abstract] [Full Text] [Related]

  • 22. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 23. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K.
    Cancer; 2003 Sep 01; 98(5):1008-13. PubMed ID: 12942569
    [Abstract] [Full Text] [Related]

  • 24. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S, Garayoa M, López-Picazo JM, Lozano MD, Toledo G, Thunnissen FB, Manzano RG, Montuenga LM.
    Clin Cancer Res; 2004 Jun 01; 10(11):3639-49. PubMed ID: 15173070
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 26. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J, Treska V.
    Anticancer Res; 2009 Jul 15; 29(7):2513-7. PubMed ID: 19596921
    [Abstract] [Full Text] [Related]

  • 27. The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC).
    Grimminger PP, Schneider PM, Metzger R, Vallböhmer D, Danenberg KD, Danenberg PV, Hölscher AH, Brabender J.
    Lung Cancer; 2010 Oct 15; 70(1):82-7. PubMed ID: 20064672
    [Abstract] [Full Text] [Related]

  • 28. Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features.
    Lee SM, Lee JY, Choi JE, Lee SY, Park JY, Kim DS.
    Cancer Genet Cytogenet; 2010 Feb 15; 197(1):39-45. PubMed ID: 20113835
    [Abstract] [Full Text] [Related]

  • 29. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R, An SJ, Chen ZH, Zhang GC, Zhu JQ, Nie Q, Xie Z, Guo AL, Mok TS, Wu YL.
    Hum Pathol; 2008 Dec 15; 39(12):1792-801. PubMed ID: 18715616
    [Abstract] [Full Text] [Related]

  • 30. Survivin gene expression in early-stage non-small cell lung cancer.
    Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S.
    J Pathol; 2003 Aug 15; 200(5):620-6. PubMed ID: 12898598
    [Abstract] [Full Text] [Related]

  • 31. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
    Yuan K, Qian C, Zheng R.
    Med Sci Monit; 2009 Nov 15; 15(11):BR313-9. PubMed ID: 19865048
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R, Hirvikoski P, Böhm J, Kellokoski J, Moisio K, Virén M, Johansson R, Hollmén S, Kosma VM.
    Hum Pathol; 2000 Sep 15; 31(9):1088-95. PubMed ID: 11014576
    [Abstract] [Full Text] [Related]

  • 34. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY.
    Clin Cancer Res; 2002 Dec 15; 8(12):3796-802. PubMed ID: 12473592
    [Abstract] [Full Text] [Related]

  • 35. Down-regulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer.
    Higashi H, Vallböhmer D, Warnecke-Eberz U, Hokita S, Xi H, Brabender J, Metzger R, Baldus SE, Natsugoe S, Aikou T, Hölscher AH, Schneider PM.
    Anticancer Res; 2006 Dec 15; 26(3A):2143-7. PubMed ID: 16827157
    [Abstract] [Full Text] [Related]

  • 36. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
    Tong XD, Liu HX, Zhao HR, Xu SG, Li Y, Han LB, Zhang L.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct 15; 28(10):741-5. PubMed ID: 17366784
    [Abstract] [Full Text] [Related]

  • 37. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
    Westerman BA, Neijenhuis S, Poutsma A, Steenbergen RD, Breuer RH, Egging M, van Wijk IJ, Oudejans CB.
    Clin Cancer Res; 2002 Apr 15; 8(4):1082-6. PubMed ID: 11948117
    [Abstract] [Full Text] [Related]

  • 38. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
    Ito S, Kawano Y, Katakura H, Takenaka K, Adachi M, Sasaki M, Shimizu K, Ikenaka K, Wada H, Tanaka F.
    Lung Cancer; 2006 Jan 15; 51(1):79-88. PubMed ID: 16225959
    [Abstract] [Full Text] [Related]

  • 39. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.
    Ai Zheng; 2004 Jul 15; 23(7):845-50. PubMed ID: 15248926
    [Abstract] [Full Text] [Related]

  • 40. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
    Takanami I.
    Oncol Rep; 2005 Apr 15; 13(4):727-31. PubMed ID: 15756449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.